Results 171 to 180 of about 100,222 (232)

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis. [PDF]

Emerg Microbes Infect
Dortet L, Moreau C, Dinh A, Bonnin RA, Escaut L, Seguret M, Weber L, Figueiredo S, Pilmis B.   +8 more
europepmc   +1 more source

Flow cytometry enables rapid evaluation of novel, new and niche antimicrobial agents. [PDF]

Front Microbiol
Salisbury E, Mulroney K, Kopczyk MK, Paton T, Carson CF, Ho WS, Chakera A.   +6 more
europepmc   +1 more source

Low levels of the second messenger c-di-GMP enhance tolerance and resistance to meropenem in <i>Pseudomonas aeruginosa</i>. [PDF]

Front Cell Infect Microbiol
Brignoli T, Ferrara S, Labrini E, Bertoni G.   +3 more
europepmc   +1 more source

Restriction Evaluation of Appropriate Carbapenem Therapy (REACT): A Multisite Observational Study. [PDF]

J Pharm Technol
Wells DA, McKnight M, Jaggar J, Cleveland KO, DeKerlegand A.   +4 more
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing <i>Klebsiella pneumoniae</i> in the hollow fiber infection model. [PDF]

Antimicrob Agents Chemother
Singh N, Jogan CML, Zang Y, Shan X, Lang Y, Karunanidhi A, Watkins JV, Curry BN, Tamma PD, Nozick SH, Ozer EA, Hauser AR, Bulitta JB, Bulman ZP.   +13 more
europepmc   +1 more source

A case of splenic abscess complicated with intra-abdominal free gas misdiagnosed as gastrointestinal perforation. [PDF]

J Surg Case Rep
Du W.
europepmc   +1 more source

<i>In vitro</i> activity of aztreonam-nacubactam and cefepime-nacubactam against a global collection of clinically important Gram-negative Bacilli collected in 2021-2023. [PDF]

JAC Antimicrob Resist
Karlowsky JA, Estabrook M, Suzuki E, Shimizu A, Okade H.   +4 more
europepmc   +1 more source